Citations

Mayo Clinic

Showing 10 of 108523 citations.

Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
George, Joseph , Patel, Tushar

Seminars in Liver Disease | January 29, 2015 | Volume: 35 | Issue: 01 | Pages: 063-074

10.1055/s-0034-1397350 | PMID 25632936 Get It

MicroRNAs and Benign Biliary Tract Diseases
O’Hara, Steven P. , Masyuk, Tatyana V. , Pisarello, María J. Lorenzo , Gradilone, Sergio A. , Masyuk, Tetyana V., Pisarello, Maria Jose Lorenzo, LaRusso, Nicholas F. , Gradilone, Sergio A

Seminars in Liver Disease | January 29, 2015 | Volume: 35 | Issue: 01 | Pages: 026-035

10.1055/s-0034-1397346 | PMID 25632932 Get It

miRNA in Liver Pathobiology, Diagnosis, and Therapy
Gores, Gregory J.

Seminars in Liver Disease | January 29, 2015 | Volume: 35 | Issue: 01 | Pages: 001-002

10.1055/s-0034-1397343 | PMID 25632929 Get It

Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
Taipaleenmäki, Hanna , Browne, Gillian , Akech, Jacqueline, Zustin, Jozef , Wijnen, André J. van , Stein, Janet L. , Hesse, Eric , Stein, Gary S., Lian, Jane B. , van Wijnen, Andre J, van Wijnen, Andre J

Cancer Research | January 29, 2015 | Volume: 75 | Issue: 7 | Pages: 1433-1444

10.1158/0008-5472.can-14-1026 | PMID 25634212 Get It

Abstract Progression of breast cancer to metastatic bone disease is linked to deregulated expression of the transcription factor Runx2. Therefore, our goal was to evaluate the potential for clinical use of Runx2-targeting miRNAs to reduce tumor growth and bone metastatic burden. Expression analysis of a panel of miRNAs regulating Runx2 revealed a reciprocal relationship between the abundance of Runx2 protein and two miRNAs, miR-135 and miR-203. These miRNAs are highly expressed in normal breast epithelial cells where Runx2 is not detected, and absent in metastatic breast cancer cells and tissue biopsies that express Runx2. Reconstituting metastatic MDA-MB-231-luc cells with miR-135 and miR-203 reduced the abundance of Runx2 and expression of the metastasis-promoting Runx2 target genes IL11, MMP-13, and PTHrP. In addition, tumor cell viability was decreased and migration suppressed in vitro. Orthotopic implantation of MDA-MB-231-luc cells delivered with miR-135 or miR-203, followed by an intratumoral administration of the synthetic miRNAs, reduced the tumor growth and spontaneous metastasis to bone. Furthermore, intratibial injection of these miRNA-delivered cells impaired tumor growth in the bone environment and inhibited bone resorption. Importantly, reconstitution of Runx2 in MDA-MB-231-luc cells delivered with miR-135 and miR-203 reversed the inhibitory effect of the miRNAs on tumor growth and metastasis. Thus, we have identified that aberrant expression of Runx2 in aggressive tumor cells is related to the loss of specific Runx2-targeting miRNAs and that a clinically relevant replacement strategy by delivery of synthetic miRNAs is a candidate for a therapeutic approach to prevent metastatic bone disease by this route. Cancer Res; 75(7); 1433–44. ©2015 AACR.
Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias
Kourelis, Taxiarchis , Kumar, Shaji , Kapoor, Prashant , Kyle, Robert A. , Lacy, Martha Q. , Hayman, Suzanne R. , Leung, Nelson , Dingli, David , Lust, John A., Lin, Yi , Zeldenrust, Stephen R., Dispenzieri, Angela , Kourelis, Taxiarchis V, Go, Ronald S. , Buadi, Francis K. , Gertz, Morie A. , Rajkumar, S. Vincent , Leung, Nelson , Dispenzieri, Angela , Dingli, David , Lin, Yi

American Journal of Hematology | January 29, 2015 | Volume: 89 | Issue: 11 | Pages: 1051-1054

10.1002/ajh.23827 | PMID 25111004 Get It

AL amyloidosis (AL) is rare and frequently remains undiagnosed until organ function is compromised, even among patients with known pre‐existing untreated plasma cell dyscrasias (PCD). We identified 168 patients with AL amyloidosis who had a prior untreated PCD. The earliest symptom or sign (s/s) was defined as the first symptom reported by the patient that could be attributed to organ dysfunction caused by AL. The interval from the time of development of s/s to the establishment of diagnosis of AL (Interval‐SA) was calculated. PCD diagnosis preceded recorded onset of s/s in 75% (114/152) of patients, with a median interval‐SA for this group of 10 months. PCD was diagnosed after s/s in 25% (38/152) of patients, with a median interval‐SA of 20 months. Overall survival (OS) from diagnosis of AL was not different between the two groups. AL amyloidosis patients with an identified pre‐existing PCD had less advanced cardiac disease at AL diagnosis when compared to a control group of AL patients without preidentified PCD. Long‐term OS was not significantly superior among patients with a pre‐identified PCD. In patients with “asymptomatic” PCD, symptoms and signs of AL amyloidosis should be solicited, since timely diagnosis is important in AL amyloidosis. Am. J. Hematol. 89:1051–1054, 2014. © 2014 Wiley Periodicals, Inc.
The effect of tendon excursion velocity on longitudinal median nerve displacement: Differences between carpal tunnel syndrome patients and controls
Filius, Anika , Thoreson, Andrew R. , Passe, Sandra, Zhao, Chunfeng , An, Kai‐Nan, Amadio, Peter C. , Wang, Yuexiang , An, Kai‐Nan

Journal of Orthopaedic Research | January 29, 2015 | Volume: 33 | Issue: 4 | Pages: 483-487

10.1002/jor.22804 | PMID 25640903 Get It

ABSTRACTThe subsynovial connective tissue (SSCT) is a viscoelastic structure connecting the median nerve (MN) and the flexor tendons in the carpal tunnel. Increased strain rates increases stiffness in viscoelastic tissues, and thereby its capacity to transfer shear load. Therefore, tendon excursion velocity may impact the MN displacement. In carpal tunnel syndrome (CTS) the SSCT is fibrotic and may be ruptured, and this may affect MN motion. In this study, ultrasonography was performed on 14 wrists of healthy controls and 25 wrists of CTS patients during controlled finger motions performed at three different velocities. Longitudinal MN and tendon excursion were assessed using a custom speckle tracking algorithm and compared across the three different velocities. CTS patients exhibited significantly less MN motion than controls (p ≤ 0.002). While in general, MN displacement increased with increasing tendon excursion velocity (p ≤ 0.031). These findings are consistent with current knowledge of SSCT mechanics in CTS, in which in some patients the fibrotic SSCT appears to have ruptured from the tendon surface. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 33:483–487, 2015.
First-Time Patellofemoral Dislocation: Risk Factors for Recurrent Instability
Lewallen, Laura, McIntosh, Amy L. , Dahm, Diane L., McIntosh, Amy, Dahm, Diane

Journal of Knee Surgery | January 29, 2015 | Volume: 28 | Issue: 04 | Pages: 303-310

10.1055/s-0034-1398373 | PMID 25633361 Get It

Evaluation of the Intermittent Exotropia Questionnaire Using Rasch Analysis
Leske, David A. , Holmes, Jonathan M. , Melia, B. Michele, Hatt, Sarah R. , Kulp, Marjean Taylor , Scheiman, Mitchell , Herlihy, Erin P. , Miller, Aaron M. , Melia, B. Michele, Holmes, Jonathan M.

JAMA Ophthalmology | January 29, 2015 | Volume: 133 | Issue: 4 | Pages: 461

10.1001/jamaophthalmol.2014.5622 | PMID 25634146 Get It

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
Agathangelidis, Andreas , Hadzidimitriou, Anastasia , Sutton, Lesley-Ann, Minga, Eva, Scarfò, Lydia , Davis, Zadie , Yan, Xiao‐Jie , Plevová, Karla , Sandberg, Yorick , Vojdeman, Fie Juhl , Boudjogra, Myriam, Τζένου, Τατιάνα , Chatzouli, Maria, Chu, Charles C. , Veronese, Silvio , Gardiner, Anne, Mansouri, Larry, Smedby, Karin E. , Pedersen, Lone Bredo , Moreno, Denis, Lom, Kirsten van, Giudicelli, Véronique , Francová, Hana Skuhrová, Nguyen‐Khac, Florence , Juliusson, Gunnar , Anagnostopoulos, Αchilles , Lefranc, Marie‐Paule , Facco, Monica , Trentin, Livio , Catherwood, Mark , Montillo, Marco , Geisler, Christian H., Pospı́šilová, Šárka , Oscier, David , Jelinek, Diane F., Darzentas, Nikos , Belessi, Chrysoula, Davi, Frédéric , Ghia, Paolo , Rosenquist, Richard , Σταματόπουλος, Κώστας , Baliakas, Panagiotis , Tsanousa, Athina , Shanafelt, Tait D. , Panagiotidis, Panagiotis T. , Angelis, Lefteris , Langerak, Anton W. , Chiorazzi, Nicholas , Ghia, Paolo , Rosenquist, Richard

Blood | January 29, 2015 | Volume: 125 | Issue: 5 | Pages: 856-859

10.1182/blood-2014-09-600874 | PMID 25634617 Get It

Key Points CLL stereotyped subset #2 (IGHV3-21/IGLV3-21) is uniformly aggressive independently of somatic hypermutation status. The prognosis for non–subset #2/IGHV3-21 CLL resembles that of the remaining CLL cases with similar somatic hypermutation status.
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
Dahlin, Jayme L. , Nissink, J. Willem M. , Strasser, Jessica M. , Francis, Subhashree, Higgins, LeeAnn, Zhou, Hui , Walters, Michael A. , Zhang, Zhiguo , Zhang, Zhiguo , Zhang, Zhiguo , Walters, Michael A

Journal of Medicinal Chemistry | January 29, 2015 | Volume: 58 | Issue: 5 | Pages: 2091-2113

10.1021/jm5019093 | PMID 25634295 Get It